Description
| Product Name | CAT.No | Size |
| Anti-Hbs Strips | HBSABS100 | 100T |
| Anti-Hbs | HBSAB020 | 20T |
| Anti-Hbs | HBSAB040 | 40T |
Product Description
The Biorex Diagnostics HBsAb Rapid Test Device is a rapid immunochromatographic assay designed for the qualitative detection of Hepatitis B surface antibody (HBsAb) in human serum or plasma. It provides fast, accurate, and reliable screening to assess immunity following vaccination or natural infection. By delivering clear qualitative results within minutes and requiring no specialised instruments, the device offers an efficient solution for both point-of-care and laboratory use.
Clinical Application and Background
Hepatitis B surface antibody serves as a key marker of acquired immunity against Hepatitis B virus (HBV). The presence of protective antibody levels indicates successful immunisation or recovery from past infection and plays a critical role in vaccination programmes, occupational health assessments, and public health surveillance. Rapid verification of immunity status is particularly important for healthcare professionals, high-risk groups, blood donors, and individuals undergoing pre-employment or pre-clinical screening. The HBsAb Rapid Test Device simplifies this process by enabling quick testing without the need for complex instrumentation or lengthy turnaround times.
Key Features
- Rapid immunochromatographic detection – clear qualitative results within minutes
- Confirmatory for HBV immunity – detects protective antibody levels ≥30 mIU/ml
- High sensitivity and specificity – reliable identification of low-titre antibodies
- Compatible with serum or plasma – minimal sample volume required
- Instrument-free testing – ideal for clinics, laboratories, and occupational health screening
- Ready-to-use format – minimal preparation, simple interpretation, reduced handling errors
Benefits
Routine use of the Biorex Diagnostics HBsAb Rapid Test Device supports the verification of Hepatitis B immunity in both clinical and public health environments. Its rapid workflow enhances vaccination monitoring programmes, supports infection prevention strategies, and ensures safer blood donation practices. In occupational health settings, rapid antibody screening provides essential information for employers and healthcare institutions, helping guide vaccination status reviews and compliance with health-and-safety protocols.
The test’s strong analytical performance, ease of use, and compatibility with common sample types improve diagnostic efficiency and reduce the need for laboratory-based immunoassays when quick decision-making is required. Suitable for hospitals, clinics, occupational health services, and community screening initiatives, the device offers a practical, cost-effective solution for confirming Hepatitis B immunity and supporting broader public health management.
Contact Us for more information.